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synGAP is a neuron-specific Ras GTPase-activating
protein found in high concentration in the postsynaptic
density fraction from mammalian forebrain. Proteins in
the postsynaptic density, including synGAP, are part of
a signaling complex attached to the cytoplasmic tail of
the N-methyl-D-aspartate-type glutamate receptor. syn-
GAP can be phosphorylated by a second prominent com-
ponent of the complex, Ca2/calmodulin-dependent pro-
tein kinase II. Here we show that phosphorylation of
synGAP by Ca2/calmodulin-dependent protein kinase
II increases its Ras GTPase-activating activity by 70–
95%. We identify four major sites of phosphorylation,
serines 1123, 1058, 750/751/756, and 764/765. These sites
together with other minor phosphorylation sites in the
carboxyl tail of synGAP control stimulation of GTPase-
activating activity. When three of these sites and four
other serines in the carboxyl tail are mutated, stimula-
tion of GAP activity after phosphorylation is reduced to
21 5% compared with 70–95% for the wild type protein.
We used phosphosite-specific antibodies to show that, as
predicted, phosphorylation of serines 765 and 1123 is
increased in cultured cortical neurons after exposure of
the neurons to the agonist N-methyl-D-aspartate.
Storage of information in the brain is mediated in part by
changes in the strength of synaptic connections between neu-
rons initiated by specific patterns of electrical activity (1).
These changes involve complex regulatory pathways that are
controlled by the pattern of influx of Ca2 ion through N-
methyl-D-aspartate (NMDA)1-type glutamate receptors
(NMDA receptors) at postsynaptic sites. Much present research
concerns the nature of the relevant biochemical pathways and
the mechanisms of Ca2 control. One set of regulatory proteins
associates tightly with the cytosolic portion of the NMDA re-
ceptor (2, 3). These include Ca2/calmodulin-dependent protein
kinase II (CaMKII) (4, 5), which is activated by Ca2 flux
through the receptor, and several proteins that are held near
the receptor by the scaffold protein PSD-95 (6, 7). A complex
containing many of these proteins can be isolated from brain
homogenates and is called the postsynaptic density (PSD)
fraction (8).
synGAP was identified as a prominent 140-kDa protein in
the PSD fraction (9, 10) and as a protein that interacts with
PSD-95 in a yeast two-hybrid screen (11). Its message is de-
tected only in brain (10, 11). It is expressed only in neurons,
including most excitatory neurons and a subset of inhibitory
neurons (12), where it is highly localized to the postsynaptic
density (10). It contains a PH domain, a C2 domain, and a Ras
GAP domain that are 23%, 33%, and 47% similar, respectively,
to those of the prototype Ras GAP protein p120 Ras GAP (13).
In brain homogenates, synGAP is tightly bound to the partic-
ulate fraction and full-length synGAP has not yet been purified
in soluble form; however, the GAP domain, expressed as a GST
fusion protein in Escherichia coli, has been shown to stimulate
hydrolysis of bound GTP by Ras (11). synGAP plays a crucial
role in early development of the brain and in control of synaptic
plasticity in the adult brain, as demonstrated by the pheno-
types of mouse synGAP mutants (14, 15). Newborn mice with
a deletion of synGAP die a few days after birth; whereas
adult mice heterozygous for the deletion have altered synaptic
plasticity (14).
In our first report of the characterization of synGAP, we
showed that it is a prominent substrate for CaMKII in the
postsynaptic density fraction and presented evidence that
phosphorylation by CaMKII reduced its GAP activity 50%
(10). We later reported that this inhibition was an artifact
caused by the combined presence of residual ATP from the
phosphorylation reaction and the phosphatase inhibitor pyro-
phosphate in our Ras GAP assay (16). Here we have identified
four of the principal phosphorylation sites for CaMKII in syn-
GAP and re-examined the regulatory effect of their phospho-
rylation. We report that phosphorylation of these sites by
CaMKII produces a 70–95% increase in the Ras GAP activity of
synGAP. Because CaMKII is a major target of calcium influx
through the NMDA receptor, this finding suggests that one
result of activation of NMDA receptors at a synapse may be an
increase in the rate of inactivation of Ras at that synapse. This
mechanism might provide a means by which NMDA receptor
activation modulates the action of receptor tyrosine kinases at
excitatory synapses.
EXPERIMENTAL PROCEDURES
Materials—Acetonitrile, UV/HPLC grade, was purchased from EM
Science (Gibbstown, NJ); HPLC/Spectra grade trifluoroacetic acid from
Pierce (Rockford, IL); iodoacetamide from Sigma (St. Louis, MO);
[-32P]ATP and [-32P]GTP from ICN Pharmaceuticals Inc. (Irvine,
CA); modified sequencing grade trypsin from Promega (Madison, WI);
C18 reversed-phase HPLC columns (4.6  250 mm) from Vydac (Hes-
peria, CA); cellulose-coated TLC sheets (20  20 mm) from EM Science;
glutathione-agarose from Sigma; and PhosphorImager screens and
scanner from Amersham Biosciences (Piscataway, NJ). Calmodulin was
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purchased from Calbiochem (San Diego, CA). CaMKII was purified
from rat forebrain as previously described (17).
Preparation of Postsynaptic Density Fraction from Rat Brain—The
crude PSD fraction was prepared as described previously (6) by a
modification of the method of Carlin et al. (18).
Expression and Purification of GST Fusion Proteins Containing Por-
tions of synGAP—A vector for expression of a fusion protein containing
a portion of the carboxyl tail of synGAP (residues 946–1167) fused to
the carboxyl terminus of glutathione S-transferase (GST-ctsynGAP)
was constructed in the pGEX plasmid, according to the manufacturer’s
instructions (Amersham Biosciences). The fusion protein contained the
sequence of synGAP encoded by positions 2836–3501 in the synGAP
cDNA (accession number AF048976). E. coli cells transformed with the
plasmids were grown in cultures containing 50 g/ml ampicillin at
37 °C. At mid-log phase, expression was induced by addition of 0.1 mM
isopropyl-1-thio--D-galactopyranoside and continued until late log
phase. Cells were harvested and frozen at 80 °C. Cells were lysed by
sonication in 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM
KH2PO4, pH 7.3 (PBS), containing 1% Triton X-100, proteinase inhib-
itor mixture (Roche Applied Science, Mannheim, Germany), 0.1 mM
PMSF, 0.5 mM dithiothreitol (DTT). After centrifugation at 15,000  g
for 10 min, lysate supernatants were incubated at room temperature for
2 h, or at 4 °C overnight with glutathione-agarose beads. In some cases,
to recover more fusion protein, the pellets were also resuspended in
PBS plus 1% n-lauroyl sarcosine, 1% Triton X-100, and 0.1 mM PMSF.
The suspension was sonicated and subjected to centrifugation at
15,000  g. The supernatant from this spin was pooled with the lysate
supernatants and incubated with glutathione-agarose beads for 2 h at
4 °C. The bead suspension was transferred to a column, and the beads
were washed with PBS. GST fusion proteins were eluted in 50 mM Tris
(pH 8.0), 20 mM reduced glutathione, and 0.1 mM PMSF at 4 °C. The
protein concentration was determined by a modification of the method
of Lowry (19) and stored at 80 °C.
Expression of synGAP in Insect Cells—The entire sequence encoding
synGAP was inserted into plasmid pVL1392 (BD Pharmingen, San
Diego, CA) at EcoR1 and BamH1 restriction sites, which added a FLAG
tag to the amino terminus. The recombinant FLAG-tagged synGAP
(rsynGAP) was expressed in Hi-5 insect cells by the Caltech Protein
Expression Laboratory. Cells were harvested by centrifugation, and the
cell pellets were frozen at 80 °C. Pellets were resuspended in 20 mM
Tris-Cl (pH 8.0), 2 mM EDTA, 2 mM DTT, 0.1 mM PMSF, 0.5% Triton
X-100, 1 g/ml deoxyribonuclease I, and protease inhibitor mixture
(Roche Applied Science) and lysed by homogenization at 4 °C. Nuclei
were removed by centrifugation at 100  g, and membranes were
harvested at 100,000 g. Like endogenous synGAP, rsynGAP is tightly
bound to membranes. All attempts to extract it resulted in loss of GAP
activity. Membrane fractions from control insect cells in which synGAP
was not present had no detectable GAP activity (data not shown); thus,
we are able to reliably measure synGAP activity in the membrane
fractions. Recombinant synGAP in the membranes was detected by
immunoblotting with an anti-FLAG antibody (Sigma).
Phosphorylation of synGAP and GST-ctsynGAP by CaMKII—Phos-
phorylation by purified CaMKII was carried out in a reaction mix
containing 50 mM Tris-HCl (pH 8.0), 10 mM MgCl2, 0.7 mM CaCl2, 0.4
mM EGTA, 30 M [-32P]ATP (1000–3000 cpm/pmol) or 30 M ATP, 10
g/ml calmodulin, 10 mM DTT, 3 g of purified rat brain CaMKII and
Hi-5 cell membranes containing 1.5–2 g of rsynGAP, or 45 ng of
purified CaMKII and 3 g of GST-ctsynGAP. Phosphorylation was
initiated by addition of CaMKII and ATP to a 30-l reaction mix
prewarmed to 30 °C for 2 min. The reaction was carried out for 2 min,
or as indicated, and stopped by the addition of SDS-PAGE sample
buffer. The mixture was placed in a boiling water bath for 3 min then
samples were fractionated by SDS-PAGE on 10% gels for GST-ctsyn-
GAP, and 7.5% gels for rsynGAP. The gels were dried and exposed to
x-ray film to identify phosphorylated proteins. To quantify the amount
of phosphate incorporated, the level of 32P in the bands was determined
with a Storm PhosphorImager (Amersham Biosciences). The relative
densities measured by the Imager were converted to counts per minute
by comparison to signals from standard amounts of [32P]phosphate
spotted onto filter paper and imaged at the same time.
Determination of Stoichiometry of Phosphorylation of synGAP by
CaMKII—The moles of synGAP per milligram of protein in either the
postsynaptic density or the membranes of Hi-5 insect cells was deter-
mined from immunoblots containing increasing amounts of protein
from each sample, labeled with affinity-purified primary antibodies
specific for synGAP (Affinity Bioreagents, Golden, CO), and secondary
antibodies conjugated to Alexa fluor-488 (Molecular Probes, Eugene,
OR). The labeling was quantified with the use of the Storm system and
compared with the labeling of standard amounts of GST-ctsynGAP
protein, which contains the epitopes of synGAP used to prepare the
primary antibody. We then calculated the nanomoles of phosphate
incorporated into the synGAP band (determined as described above) per
nanomoles of total synGAP.
Trypsinization of Phosphorylated GST Fusion Proteins and Recom-
binant synGAP—Proteins were phosphorylated as described above with
the following modifications. The reaction was conducted in a volume of
500 l containing 80–120 g/ml GST fusion protein or 300–400 g/ml
Hi-5 membrane protein containing recombinant synGAP. The reaction
mixture was preincubated at 30 °C for 5 min, and the reaction was
initiated by addition of 2–4 g/ml CaMKII for phosphorylation of GST
fusion protein or 10–20 g/ml CaMKII for phosphorylation of mem-
brane-bound recombinant synGAP in the presence of 30 M [-32P]ATP
(1500–3000 cpm/pmol). The reaction was continued for 5, 15, or 30 min
at 30 °C and stopped by addition of 3 SDS sample buffer. The mixture
was placed in a boiling water bath for 3 min then fractionated by
SDS-PAGE. The gel was stained with Coomassie Blue R-250, and the
appropriate band of GST fusion protein or recombinant synGAP was
identified by comparison to molecular weight markers. Bands were
FIG. 1. Stoichiometry of phosphorylation of synGAP by
CaMKII. Recombinant synGAP (2 g) in a Hi-5 membrane fraction
(solid line) was phosphorylated in the presence of exogenous purified
CaMKII (3 g). Native synGAP (2.6 g) in the PSD fraction (dashed
line) was phosphorylated with the endogenous CaMKII present in the
PSD fraction (total PSD protein, 50 g). Reactions were carried out in
the presence of [-32P]ATP (1000 cpm/pmol), Ca2, and calmodulin, as
described under “Experimental Procedures.” At the indicated times,
reactions were stopped by addition of SDS-PAGE sample buffer. Radio-
labeled synGAP was fractionated by SDS-PAGE on 7.5% gels and
visualized with a PhosphorImager. [-P32]PO4 in the synGAP protein
band was quantified with the use of ImageQuaNT software from Am-
ersham Biosciences, as described under “Experimental Procedures.”
FIG. 2. Effect of phosphorylation of synGAP by CaMKII on Ras
GAP activity. Ras GAP activity was assayed before and after phos-
phorylation of synGAP by CaMKII as described under “Experimental
Procedures.” synGAP in the PSD fraction (15 g of total PSD protein)
was phosphorylated by endogenous CaMKII. Recombinant synGAP (15
g of Hi-5 cell membrane protein) was phosphorylated by 3 g of added
purified CaMKII. Phosphorylation of synGAP was carried out in the
absence (Ca) or presence (Ca) of 0.7 mM CaCl2 and 0.6 M calmod-
ulin (10 g/ml) for 2 min at 30 °C. Data are mean values from four
independent experiments. GAP activities are plotted after subtraction
of intrinsic Ras GTPase activity and are normalized to the activity of
nonphosphorylated synGAP. Non-normalized GAP activity, before
phosphorylation and after subtraction of the intrinsic Ras GTPase
activity, was 11.6% hydrolysis of GTP for synGAP in the PSD fraction
and 19% for recombinant synGAP. The mean intrinsic Ras GTPase
activity was 6.0% hydrolysis of GTP.
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excised, chopped into small pieces, and transferred to 1.5-ml Eppendorf
tubes. The pieces were incubated for 30 min at 37 °C in 2 mM tris-(2-
carboxyethyl)phosphine hydrochloride, 50% acetonitrile, 0.5 M ammo-
nium bicarbonate (pH  8) to reduce the protein and destain the gel
piece. The protein was then alkylated by transferring the gel piece to 25
mM iodoacetamide, 50% acetonitrile, 25 mM ammonium bicarbonate
and incubating at room temperature in the dark for 20 min. Gel pieces
were rinsed with 50 mM ammonium bicarbonate. Proteins were then
trypsinized in the gel as previously described (20).
HPLC Fractionation of Phosphopeptides—Trypsinized phosphopep-
tides were fractionated by HPLC on a C18 reversed-phase column
developed at 1 ml/min with a gradient of 0–30% acetonitrile in 0.1%
trifluoroacetic acid. Radioactivity in each 0.5-ml fraction was measured
in a Beckman LS 7800 scintillation counter by detection of Cerenkov
radiation.
Mass Spectrometry and Sequencing of Phosphopeptides—Mass spec-
trometry was conducted by the Protein and Peptide Microanalytical
Laboratory at Caltech with a PerSeptive Biosystems/Vestec Lasertech
II reflector for matrix-assisted, laser desorption ionization, time-of-
flight (MALDI-TOF) mass spectrometry. Data were collected in both
linear and reflector modes. Serine phosphopeptides are reliably identi-
fied by appearance of a new peptide in reflector mode that is reduced in
mass by 98 atomic mass units from the parent because of cleavage of
a phosphate group from the parent. The identity of some of the phos-
phopeptides that we detected was confirmed by amino acid sequencing
by Tandem mass spectrometry (MS/MS).
Identification of Tryptic Peptides with Peptidesort Software—The
Peptidesort software package (GCG, Accyleris, Inc.) permits identifica-
tion of a peptide from its molecular mass and its relative retention time
during HPLC. We used the program to predict all possible tryptic
peptides, sorted by retention time and molecular mass, from the amino
acid sequence of synGAP. We compared the retention times from HPLC
and the molecular masses of each phosphopeptide that we detected by
mass spectrometry with those predicted by the program. Mass spec-
trometry measures the mass of the peptide fragment plus a proton,
whereas the program predicts the mass of the corresponding hydrolysis
product. Therefore, for comparison, we subtracted 17 atomic mass units
from the mass of each peptide predicted by the program. After this
correction, unless noted, the differences between masses predicted by
the program, and those of peptides determined by mass spectrometry
and reported in Tables I and II (see below), were less than 1 atomic
mass unit.
Assay of Ras GTPase-activating Activity—GAP assays of 20–35 g of
PSD and 5–15 g of recombinant synGAP were performed after phos-
phorylation as described above, in the absence or presence of 0.3 mM
free Ca2 and 10 g/ml calmodulin for 2 min at 30 °C, but in a final
volume of 30 l. In some reactions, antibody 6G6 against PSD-95 or
inhibiting antibodies 4A11 and 6E9 (21) against CaMKII (20 g each of
IgG partially purified from Ascites fluid by precipitation with 50%
ammonium sulfate) were included in the reaction. The phosphorylation
reactions were stopped by addition of 60 l of a mixture to bring the
solution to 0.66 mM EGTA, 11.7 M okadaic acid, 22 mM Tris-Cl (pH
7.5), 9.3 mM MgCl2, 111 mM NaCl, and 2.2 mM DTT. The GAP assay was
then initiated by addition of 10 l containing 2 pmol of [-32P]GTP-
bound GST-Ras fusion protein (10) for a total volume of 100 l of GAP
reaction mixture (22). The reactions were carried out at 30 °C for 15
min, stopped by addition of 600 l of ice-cold 5% glutathione-agarose
beads and 80 l of ice-cold 50 mM EDTA, and then incubated at 4 °C for
45 min on an end-over-end mixer. Beads were washed three times (23),
nucleotides were dissociated from the column-bound GST-Ras, and
[-32P]GTP and [-32P]GDP were separated by thin layer chromatogra-
phy (22). The separated nucleotides were visualized by PhosphorImager
analysis (Amersham Biosciences) and quantified with ImageQuaNT
software to determine the percent GDP generated in the assay (GDP/
[GDP  GTP]  100), a measure of Ras GTPase activity.
Site-directed Mutagenesis of Recombinant synGAP—We prepared
various mutant constructs to study the effect of mutation of the iden-
tified phosphorylation sites to alanine (serines 764, 765, 1058, 1062,
1064, 1093, 1095, and 1123). Mutagenic oligonucleotides (18- to 25-mer)
that contained alanine instead of the identified serine were synthesized
at the Caltech Oligonucleotide Synthesis Laboratory. The oligonucleo-
tides were phosphorylated at the 5 end by T4 kinase then annealed to
the denatured synGAP plasmid (pVL1392) at room temperature for 30
min. The oligonucleotides were extended with T4 DNA polymerase and
T4 DNA ligase in vitro to generate a hemi-methylated, double-stranded
DNA molecule. A restriction digestion was performed with Dpn-1 to
eliminate non-mutant plasmid DNA (those with two methylated
strands). The DNA molecules were then transformed into the E. coli
mutS strain (deficient in the methylation-specific repair system), and
colonies were screened by DNA sequencing for plasmids containing the
alanine mutations (24). Plasmids containing the desired mutations
were transformed into E. coli DH5 for propagation, and mutations
were confirmed by DNA sequencing.
Production of Phosphosite-specific Antibodies—Synthetic peptides
with the sequence ITKQH-S(PO3)-QTPSTC (P-S1123) and RGLNS-
S(PO3)-MDMARC (P-S765) were purchased from SynPep (Dublin, CA).
Purified peptides were conjugated via succinimidyl 4-(N-maleimidom-
ethyl)cyclohexane-1-carboxylate to keyhole limpet hemocyanin. Rabbit
antisera against the conjugated P-S1123 and P-S765 were raised by
CoCalico Biologicals (Reamstown, PA) and Sigma Genosis (The Wood-
lands, TX), respectively. Specificity and optimum dilution were deter-
mined for each bleed by immunoblotting against 15–20 g of PSD
fraction phosphorylated by endogenous CaMKII, and of equivalent non-
phosphorylated PSD fraction. Antibodies from sera that contained a
high titer specific for phospho-synGAP were purified by peptide
affinity chromatography.
Five milligrams of P-S1123 or P-S765 peptide was conjugated to 5 ml
of Sulfolink coupling resin (Pierce, Rockford, IL) according to the man-
ufacturer’s instructions. The coupled resin was then mixed for 1 h with
FIG. 3. Increase in the GAP activity of synGAP depends on
CaMKII. A, dependence on amount of CaMKII in the phosphorylation
reaction. Recombinant synGAP (15 g) was phosphorylated for 2 min at
30 °C in the presence of the indicated amounts of purified forebrain
CaMKII, then assayed for GAP activity as described under “Experimen-
tal Procedures.” f, phosphorylation in the absence of CaCl2 and cal-
modulin; Œ, phosphorylation in the presence of CaCl2 and calmodulin.
B, effect of antibodies that inhibit CaMKII on the increase in GAP
activity. Monoclonal antibodies 6E9 and 4A11, which inhibit CaMKII
activity, were incubated with the PSD fraction (15 g of each) at 4 °C for
30 min, and then phosphorylation was carried out at 30 °C in the
presence of CaCl2 and calmodulin as described above. In two control
reactions, either mouse IgG or an anti-PSD-95 antibody (6G6) were
substituted for inhibiting antibodies. The data are mean values of three
independent experiments. GAP activities are plotted after subtraction
of the intrinsic Ras GTPase activity and are normalized to the activity
of nonphosphorylated synGAP. Non-normalized GAP activity, before
phosphorylation and after subtraction of intrinsic Ras GTPase activity,
was 14.5% hydrolysis of GTP in the presence of mouse IgG (MigG),
12.5% in the presence of 6G6, and 15.2% in the presence of 6E9 plus
4A11. The mean intrinsic Ras GTPase activity was 6.8% hydrolysis of
GTP.
Regulation of synGAP by CaMKII17982
a blocker consisting of 0.1 M cysteine in TE85 (50 mM Tris, pH 8.5, 5 mM
EDTA), then washed twice with 5 volumes each of TE85, TE85, 1 M
NaCl, and finally with 50 mM Tris, pH 7.5, 5 mM EDTA (TE75). Before
each use, the resin was blocked for 1 h with 3 volumes of TE75, 20%
non-immune rabbit serum, washed with TE75, G elution buffer
(Pierce), and finally re-equilibrated with TE75 buffer. IgG from 25 ml
of serum was concentrated by precipitation in 50% ammonium sulfate,
0.1 M Tris-Cl, pH 7.5. The pellet was redissolved in 50 ml of TE75 and
dialyzed against two changes of the same buffer. The dialyzed protein
was stirred with the peptide resin for 2 h, poured into a column, and
washed with 10 column volumes of TE75. Bound IgG was eluted in
Gentle Elution Buffer (Pierce), collecting 1-ml fractions into tubes con-
taining 0.1 ml of 1 M Tris-Cl, pH 7.5. Protein was detected in each
fraction by absorbance at 280 nm. Fractions containing high amounts of
protein were further characterized by immunoblotting against both
phosphorylated and nonphosphorylated PSD protein. Fractions with
the highest concentration of phosphosite-specific antibodies were
pooled.
Preparation of Cortical Neuronal Cultures—Cultures of cortical neu-
rons with less than 1% astrocytes were prepared from fetal mice (15–16
days gestation) as previously described (25) in 24-well plates coated
with 50 ng/ml poly-D-lysine (Sigma) and 2 ng/ml laminin (BD Bio-
sciences) and Neurobasal medium (Invitrogen), B27 supplement (In-
vitrogen), 0.5 mM Glutamax I (Invitrogen), 25 M glutamate, and 25 M
-mercaptoethanol. After 3 days in vitro (DIV), cytosine arabinoside
(Sigma) was added (10 M) to halt the growth of non-neuronal cells.
Cells were used at 13–14 DIV.
Cell Treatment and Protein Extraction —Cell cultures (13–14 days in
vitro (DIV)) were washed three times in HEPES-control salt solution
(HCSS) containing (in mM): 120 NaCl, 5.4 KCl, 0.8 MgCl2, 1.8 CaCl2, 10
NaOH, 20 HEPES, and 5.5 glucose, pH 7.4, and then half were exposed
to 25 M N-methyl-D-aspartic acid (NMDA) dissolved in HCSS or to an
equal amount of additional HCSS for 15 s (2–4 wells for each condition).
After treatment, cells were washed quickly with ice-cold PBS and
extracted with lysis buffer (1% SDS, 20 mM Tris-Cl, pH 7.5, 10 mM
EGTA, 40 mM -glycerophosphate, 2.5 mM MgCl2, 2 mM orthovanadate,
and complete mini protease inhibitor mixture (Roche Applied Science)).
Extracts were heated at 90 °C for 5 min, and insoluble material was
removed by centrifugation at 14,000  g for 30 min. Protein concentra-
tions were determined by the bicinchoninic acid method (Pierce) using
bovine serum albumin as standard.
Western Blotting—To determine synGAP phosphorylation, 5 g of
protein samples was dissolved in SDS-PAGE sample buffer, heated at
90 °C for 5 min, fractionated by SDS-PAGE on 8% gels, and transferred
to nitrocellulose membranes (Schleicher & Schuell) in transfer buffer
containing 50 mM Tris, 380 mM glycine, 0.1% SDS, and 20% methanol.
Membranes were blocked with 5% milk in TBS-T buffer (20 mM Tris,
150 mM NaCl, 0.05% Tween 20) and were then incubated with phos-
phorylation site-specific antibodies anti-p-synGAP-1123 (1:5,000), anti-
p-synGAP-765 (1:10,000) or antibody recognizing total synGAP
(1:3,000). Bound antibodies were detected by the enhanced chemilumi-
nescence method (Pierce).
RESULTS
Stoichiometry and Rate of Phosphorylation of synGAP by
CaMKII—synGAP in the postsynaptic density and recombi-
nant synGAP are phosphorylated rapidly and to a high stoichi-
ometry by CaMKII (Fig. 1). We were unable to remove synGAP
from the PSD fraction or from Hi-5 cell membranes without
destroying its GAP activity; therefore, we performed the exper-
iments with synGAP in the PSD fraction phosphorylated by
endogenous CaMKII, and with recombinant synGAP in Hi-5
cell membranes phosphorylated by purified rat forebrain
CaMKII, as described under “Experimental Procedures.” The
most rapid phosphorylation occurs within 2 min after which
synGAP contains 3–3.5 mol of phosphate/mol, suggesting
that there are three to four preferred sites of phosphorylation
by CaMKII.
The Ras-GTPase Activating Activity of synGAP Is Increased
after Phosphorylation by CaMKII—We had previously reported
that the Ras GAP activity of synGAP is inhibited about 2-fold
after phosphorylation by CaMKII (10). We later found that this
observation was caused by inhibition of GAP activity by ATP
and pyrophosphate added to inhibit endogenous protein phos-
phatases (16). We re-investigated regulation of GAP activity of
synGAP by CaMKII, after optimizing conditions for the GAP
assay in the absence of pyrophosphate, as described under
“Experimental Procedures.” To preserve the phosphorylation
state of synGAP during the GAP assay (15 min), we added
EGTA and 3.5 M okadaic acid at the end of the phosphoryla-
tion reaction. These agents fully inhibited dephosphorylation of
synGAP and did not interfere with the GAP assay (data not
shown). We then redetermined conditions under which the
GAP activity is linear with time and with amount of synGAP.
Under these conditions, phosphorylation by CaMKII increased
the GAP activity of synGAP in the PSD fraction by 75% and
of recombinant synGAP by  95% (Fig. 2).
To verify that phosphorylation by CaMKII is responsible for
the increase in activity, we determined the dependence of the
increase on the amount of exogenous CaMKII in the phospho-
rylation reaction (Fig. 3A). When no CaMKII was added to the
assay, GAP activity was not increased. The importance of phos-
phorylation by CaMKII for the increase in GAP activity was
further supported by an experiment in which we added inhib-
iting antibodies against CaMKII to the phosphorylation reac-
tion (Fig. 3B). The increase in GAP activity in the PSD fraction
was decreased when antibodies that inhibit CaMKII (4A11 and
6E9) were included in the phosphorylation reaction but was
unaffected by addition of non-immune mouse IgG or an anti-
body against PSD-95 (6G6).
Identification of Phosphorylation Sites in the Carboxyl-termi-
nal Portion of synGAP—We constructed and expressed various
fusion proteins containing portions of synGAP and tested them
for phosphorylation by CaMKII as described under “Experi-
mental Procedures.” The fusion protein containing the carbox-
yl-terminal fragment of synGAP (amino acids 946–1167) was
rapidly phosphorylated (data not shown), therefore we identi-
fied its phosphorylation sites. Tryptic peptides were generated
from the phosphorylated protein and fractionated by HPLC as
described under “Experimental Procedures.” Four major peaks
FIG. 4. Tryptic phosphopeptides generated from the GST-
ctsynGAP fusion protein after phosphorylation by CaMKII. Pu-
rified GST-ctsynGAP fusion protein (60 g), containing residues 946–
1167 of synGAP, was phosphorylated for 30 min in the presence of
[32P]ATP at 30 °C. The phosphorylated protein was fractionated by
SDS-PAGE and digested in the gel with trypsin as described under
“Experimental Procedures.” Tryptic peptides were eluted and fraction-
ated by HPLC, and the indicated radiolabeled tryptic peptides were
identified by mass spectrometry as described under “Experimental Pro-
cedures” (Table I and Fig. 5). Peaks are labeled with the fraction
number (#) and the location of phosphorylated sites in full-length syn-
GAP corresponding to the phosphopeptide in the peak. Fractionation of
trypsinized fusion protein after 5 and 15 min of phosphorylation pro-
duced peaks with the same retention times. Dashed line, acetonitrile
concentration.
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of radioactivity appeared reproducibly (Fig. 4). The same four
peaks were present after 5, 15, or 30 min of phosphorylation,
with the size of the peaks proportional to the time of phospho-
rylation, indicating that all the peaks represent sites that are
phosphorylated at approximately the same rate. Individual
fractions containing the peaks were concentrated and subjected
to MALDI-TOF mass spectrometry in both linear and reflector
modes. In reflector mode, neutral loss of H3PO4 from serine and
threonine phosphopeptides usually produces a new peptide
peak with a mass of 98 atomic mass units less than that of the
phosphopeptide itself (26). The appearance of this peak is di-
agnostic for a phosphopeptide. Each of the four samples showed
one such new peak in reflector mode (Fig. 5 and Table I),
permitting us to identify the mass of the phosphopeptide in
each sample. Three of the four phosphopeptides were pure
enough to sequence by MS/MS as described under “Experimen-
tal Procedures.” The sequences revealed that fractions 77, 95,
and 103 contained phosphorylated sites corresponding to
serines 1058, 1099, and 1123 in full-length synGAP, respec-
tively (Table I). The masses of the predicted tryptic peptides
calculated with the program Peptidesort corresponded to those
determined by mass spectrometry, confirming the identities of
these phosphopeptides. The recovery of the phosphopeptide in
fraction 202 was too low for sequencing by MS/MS. Its pre-
dicted mass could correspond to one of two peptides: a peptide
containing residues 970–1004, which contains 7 serines and 3
threonines, or a peptide containing residues 1056–1090 result-
ing from partial tryptic digestion of the region containing phos-
phorylation site serine 1058. The predicted masses of both of
these peptides are slightly greater than 1 atomic mass unit
different from the mass determined by mass spectrometry (Ta-
ble I). Thus, the identity of this phosphopeptide remains am-
biguous. Its low abundance suggests either that it is a partial
digestion product, or that it may not be a preferred phospho-
rylation site.
Identification of Additional Phosphorylation Sites after Mu-
tation of S1058 and S1123 in Full-length synGAP—To check
for additional phosphorylation sites in synGAP, we constructed
and expressed full-length synGAP in which the two major
phosphorylation sites, S1058 and S1123, were mutated to ala-
nine (S1058/1123A) as described under “Experimental Proce-
dures.” This mutant protein was still rapidly phosphorylated
by purified CaMKII but to a stoichiometry of only 1.5 mol of
PO4/mol of synGAP compared with 3–3.5 for wild type synGAP
(Fig. 1), indicating that the two mutated sites are indeed major
sites phosphorylated rapidly in the native protein. However,
the stoichiometry of greater than 1 indicated that additional
sites might be present in the portions of synGAP that were not
contained in GST-ctsynGAP or might be unmasked in the car-
boxyl-terminal portion by mutation of the major sites. A tryptic
peptide map of the phosphorylated S1058/1123A mutant, pre-
pared as described in the previous section, revealed five major
phosphopeptide peaks (Fig. 6). MALDI-TOF mass spectrome-
try in linear and reflector modes, revealed the mass of phos-
phopeptides in fractions 79, 88, and 214 (Fig. 7 and Table II).
Fractions 98 and 152 contained several peptides, but none of
them could be positively identified as a phosphopeptide. We
were able to match the masses of phosphopeptides determined
FIG. 5. Mass spectrographs of phos-
phopeptides from the GST-ctsynGAP
fusion protein. Postsource decay spec-
tra of phosphopeptide peaks 77 (A), 95
(B), 103 (C), and 202 (D) shown in Fig. 4.
The ordinates are detector counts. Each
spectrum shows corrected masses (M 
H) of peptides run in reflector mode in a
MALDI-TOF spectrometer. The larger
mass is that of the phosphopeptide. The
smaller mass is that of the peptide after
neutral loss of phosphate (98).
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by mass spectrometry and their relative retention times during
HPLC with those predicted in the program Peptidesort for
specific tryptic peptides (Table II). The phosphopeptide in frac-
tion 79 is predicted to contain two serines at positions 1093 and
1095 in synGAP. The prominent phosphopeptide in fraction 88
is predicted to contain two adjacent serine residues at positions
764 and 765. The phosphopeptide in fraction 214 contains three
serines at positions 750, 751, and 756. The two pairs of serines,
750/751 and 764/765, are located in two 13 residue tandem
repeats that are 61% identical. These five potential sites be-
tween positions 750 and 765 are outside the region of the
protein contained in GST-ctsynGAP and represent potential
major sites of phosphorylation. In contrast, sites 1093 and 1095
were present in GST-ctsynGAP but were not significantly phos-
phorylated in the presence of Ser-1058 and Ser-1123 (Fig. 4),
indicating that these sites may be minor sites in the wild type
protein that are “unmasked” in the mutant. We could not
identify the phosphoprotein present in fraction 98, but its re-
tention time is similar to that of the peak containing phospho-
rylation site 1099 in Fig. 4; thus, Ser-1099 may be significantly
phosphorylated in both mutant and wild type synGAP.
The Major Phosphorylation Sites, Serines 764/765, 1058, and
1123, All Contribute to Regulation of GAP Activity of synGAP
by CaMKII—To determine which of the identified phosphoryl-
ation sites are responsible for regulation of the GAP activity of
synGAP, we generated a series of synGAP mutants in which
several of the phosphorylation sites, or combinations of them,
were mutated to alanine. We then measured the GAP activity
after phosphorylation of these mutants by CaMKII as de-
scribed in Fig. 2. The increase in GAP activity produced by
phosphorylation was reduced from70% to 40% in a mutant
in which both Ser-764 and Ser-765 were changed to alanine
(Fig. 8). In contrast, a mutant missing both Ser-1058 and
Ser-1123 phosphorylation sites still showed nearly a 70% in-
crease in GAP activity after phosphorylation. Three of the
other identified phosphorylation sites, 1093, 1095, and 1099,
are located near 1058 and 1123 and are phosphorylated in the
mutant that is missing 1058 and 1123. It is possible that
phosphorylation, of those sites or of other nearby serines such
as 1062 and 1064, can mimic the effect of the phosphorylation
of 1058 and 1123. Therefore, we designed a carboxyl-terminal
synGAP mutant (ctm) in which six of the potential phosphoryl-
ation sites, including 1058, 1062, 1064, 1093, 1095, and 1123,
are mutated to alanine. (We have not yet successfully mutated
site 1099 to alanine.) The increase in GAP activity induced by
phosphorylation of this mutant (termed the ctm mutant) was
reduced to about 40%, similar to the increase observed for the
764/765 mutant (Fig. 8). We decided to determine the increase
in GAP activity in a mutant in which all eight of these serine to
alanine mutations are combined. In this mutant, the increase
in GAP activity after phosphorylation was reduced to 20%
(Fig. 8). Thus, it appears that these phosphorylation sites all
can contribute to the regulation of GAP activity by CaMKII. It
is possible that the remaining 20% increase in GAP activity
results from phosphorylation of serines 750, 751, 756, or 1099,
which we have not yet mutated.
Activation of NMDA Receptors Increases Phosphorylation of
synGAP on Ser-1123 and Ser-765 in Cortical Neurons—We
raised phosphosite-specific antibodies against phosphorylated
peptides containing the sequences surrounding Ser-765 and
Ser-1123, as described under “Experimental Procedures.” After
affinity purification on columns substituted with the peptide
antigens, these antibodies are highly specific for phosphoryl-
ated synGAP on immunoblots of the PSD fraction (Fig. 9A). To
FIG. 6. Tryptic phosphopeptides generated from recombinant
synGAP missing sites S1058 and S1123 after phosphorylation by
CaMKII. A cDNA encoding synGAP with two mutations, S1058A and
S1123A (henceforth referred to as S1058/1123A), was expressed in Hi-5
cells as described under “Experimental Procedures.” The mutant pro-
tein (200 g) was phosphorylated for 30 min at 30 °C, as described
under “Experimental Procedures.” The phosphorylated protein was
fractionated by SDS-PAGE and digested in the gel with trypsin as
described under “Experimental Procedures.” Tryptic peptides were
eluted and fractionated by HPLC, and the indicated radiolabeled tryptic
peptides were identified by mass spectrometry as described under “Ex-
perimental Procedures” (Table II and Fig. 7). Peaks are labeled with the
fraction number (#) and the location of phosphorylated sites in full-
length synGAP corresponding to the phosphopeptide in the peak. Frac-
tions 98 and 152 had detectable radioactivity, however, no phosphopep-
tides were detected in them by MALDI-TOF mass spectrometry in the
reflector mode.
TABLE I
Identification of phosphopeptides in HPLC fractions shown in Fig. 4
The molecular masses of phosphopeptides shown in Fig. 4 were determined by MALDI-TOF mass spectrometry (Fig. 5). The identity of the
phosphopeptide in fraction 202 is ambiguous, because two peptides, a partial tryptic product containing site S1058 and a tryptic peptide containing
7 serines and 3 threonines, have masses slightly more than 1 atomic mass unit different from the determined mass.
HPLC fractions Identified sites
Peptide mass
(MALDI-TOF) Predicted peptide massb Residues in synGAP
Linear Reflecteda
atomic mass units
77c S1058 1678.78 1581.72 1580.87 1056–1070
95c S1099 2054.10 1956.32 1957.10 1097–1120
103c S1123 2045.28 1947.83 1948.10 1121–1138
202 S1058 or 7 Ss, 3 Ts 3770.06 3672.46 3674.06 or 3673.90 1056–1090 or 970–1004
a Mass of peptide after neutral loss of phosphate in reflector mode.
b The mass of peptides predicted from tryptic hydrolysis in Peptidesort software were corrected by subtracting 17 atomic mass units to match
the M  H mass measured by MALDI-TOF.
c Identity of phosphopeptide was confirmed by sequencing by MS/MS as described under “Experimental Procedures.”
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determine whether Ser-765 or Ser-1123 can undergo phospho-
rylation in neurons, cortical cultures were exposed to 25 M
NMDA for 15 s, after which the cultures were extracted with
SDS-PAGE sample solution. Immunoblots of extracts from con-
trol and treated cultures were prepared and probed with the
antibodies against phosphosites and with antibodies against
synGAP to control for sample loading. As shown in Fig. 9B,
treatment of the cultures with NMDA resulted in an increase
in phosphorylation of synGAP on both sites, indicating that
these sites can be phosphorylated in vivo following activation of
NMDA receptors.
DISCUSSION
synGAP is an Ras GTPase-activating protein that was orig-
inally discovered as an abundant PSD protein that associates
with the NMDA-receptor scaffold protein PSD-95 (10, 11). It is
a prominent component of a signaling complex that associates
with the cytosolic face of the NMDA receptor at postsynaptic
spines of excitatory synapses in the central nervous system and
regulates a wide variety of synaptic functions in the developing
and adult nervous systems (3, 27). Mouse mutants in which
synGAP is eliminated by homologous recombination die in the
first or second week after birth, indicating that synGAP is
essential for viability after birth (14, 15). synGAP is phospho-
rylated by the Ca2-regulated protein kinase CaMKII, which is
one of the major targets of Ca2 flowing through activated
NMDA receptors. To better understand how synGAP may par-
ticipate in synaptic regulation through the NMDA-receptor, we
set out to characterize how synGAP is modified by CaMKII.
We report here that phosphorylation of synGAP by CaMKII
increases its GAP activity by 70–95%. The increase in activity
is observed both when native synGAP present in the PSD
fraction is phosphorylated by CaMKII that is endogenous to the
PSD fraction, and when recombinant synGAP in Hi-5 cell mem-
branes is phosphorylated by CaMKII purified from rat fore-
brain. synGAP is phosphorylated rapidly at several sites in its
carboxyl half (Fig. 10), including serines 751/752 and/or 756,
serines 764/765, serine 1058, and serine 1123. We have not
distinguished between the two sets of adjacent serines, 751/
752/756 and 764/765; it seems likely that the adjacent serines
may be phosphorylated interchangeably in individual mole-
FIG. 7. Mass spectrographs of phos-
phopeptides from synGAP mutant
missing sites 1058 and 1123. Post-
source decay spectra of phosphopeptide
peaks 79 (A), 88 (B), and 214 (C) shown in
Fig. 6. The ordinates are detector counts.
Each spectrum shows corrected masses
(M  H) of peptides run in reflector
mode in a MALDI-TOF spectrometer. The
larger mass is that of the phosphopeptide.
The smaller mass is that of the peptide
after neutral loss of phosphate (98).
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cules. Experiments with phosphosite-specific antibodies that
recognize synGAP when it is phosphorylated at serine 765 or at
serine 1123 indicate that phosphorylation of both of these sites
is increased in cortical neurons within 15 s after activation of
NMDA receptors. We have not yet determined whether phos-
phorylation of these sites in living neurons is catalyzed exclu-
sively by CaMKII. Other sites on synGAP that may also be
phosphorylated, but appear from our biochemical results to be
less favored, include serines 1093, 1095, and 1099. We gener-
ated mutants in which all of the phosphorylated residues,
except serines 751, 752, 756, and 1099, were changed to ala-
nine, singly or in combination. Measurement of GAP activity
after phosphorylation of the mutants by CaMKII shows that no
single site is responsible for the entire increase in activity.
Mutation of serines 764/65 or of serines 1058 and 1123 de-
creases the level of activation by CaMKII. After mutation of six
of the identified sites, phosphorylation of CaMKII still in-
creases GAP activity by 20%. Thus, there are likely addi-
tional sites, perhaps serines 751,752, 756, 1099, or sites that we
have not yet identified, at which phosphorylation can produce
a small increase in GAP activity.
It is interesting that several of the phosphorylation sites that
we identified (1058, 1093/95, 1099, and 1123) are located in a
region of high disorder spanning residues 1014–1144 (data not
shown), as predicted by the software PONDRs (Predictor of
Natural Disordered Regions, supplied by A. K. Dunker, Wash-
ington State University, Pullman, WA (28–30)). Disordered
regions are predicted to be partially or fully unfolded, and,
thus, to lack a fixed tertiary structure. PONDRs has been used
to detect an association between regions of intrinsic disorder
and signaling functions in cell-signaling proteins (31, 32). Such
TABLE II
Identification of phosphopeptides in HPLC fractions shown in Fig. 6
The molecular masses of phosphopeptides shown in Fig. 6 were determined by MALDI-TOF mass spectrometry (Fig. 7). Phosphopeptides in
fractions 79, 88, and 214 were identified by comparison with retention order and molecular masses predicted by the Peptidesort program, as
described under “Experimental Procedures.”
HPLC fractions Identified sites
Peptide mass (MALDI-TOF)
Predicted peptide massb Residues in synGAP
Linear Reflecteda
atomic mass units
79 S1093/1095 1023.6 926.3 926.1 1089–1096
88 S764/765 1161.6 1064.2 1064.2 761–770
214 S750/751/756 1676.8 1579.3 1579.7 747–760
a Mass of peptide after neutral loss of phosphate in reflector mode.
b The mass of peptides predicted from tryptic hydrolysis in Peptidesort software were corrected by subtracting 17 atomic mass units to match
the M  H mass measured by MALDI-TOF.
FIG. 8. Loss of regulation of GAP activity in phosphosite mu-
tants of synGAP. The indicated synGAP mutants were generated by
site-directed mutagenesis and expression in Hi-5 cells as described
under “Experimental Procedures.” GAP assays were performed for 15
min after phosphorylation by CaMKII in the presence or absence of
Ca2/CaM for 2 min as described under “ Experimental Procedures.”
The data are mean values from four or more independent experiments.
GAP activities are plotted after subtraction of intrinsic Ras GTPase
activity and are normalized to the activity of non-phosphorylated syn-
GAP. Non-normalized GAP activity, before phosphorylation and after
subtraction of Ras GTPase, was 14% hydrolysis of GTP for wt synGAP;
11.8% for S1058/1123A; 14.1% for S764/5A; 17.2% for ctm (S1058A,
S1062A, S1064A, S1093A, S1095A, and S1123A); and 17.4% for
S764/5A plus ctm. The mean intrinsic Ras GTPase activity was 6.5%
hydrolysis of GTP.
FIG. 9. Phosphorylation of sites 765 and 1123 is regulated in
vivo by activation of NMDA-type glutamate receptors. A, antisera
against synthetic phosphopeptides with the sequence surrounding ser-
ine 765 or serine 1123 in synGAP were generated, and sera with high
titers were affinity-purified on columns substituted with the appropri-
ate antigenic peptide, as described under “Experimental Procedures.”
Fractions were assayed by immunoblotting against purified postsynap-
tic density proteins before or after phosphorylation by CaMKII, as
described under “Experimental Procedures.” Fractions with the great-
est specificity for phospho-synGAP were pooled. Immunoblots of non-
phosphorylated () and phosphorylated () postsynaptic density pro-
teins were made with 1/20,000 dilutions of the pooled antibodies. The
area shown in the figure includes proteins at the top of the gel down to
molecular mass 96 kDa. Arrows indicate the top of the gel and the
position of synGAP. B, cultures of cortical neurons prepared as de-
scribed under “Experimental Procedures” were exposed to 25 M N-
methyl-D-aspartate or to vehicle for 15 s, as described under “Experi-
mental Procedures.” Cultures were immediately dissolved in SDS-
PAGE sample solution, boiled, fractionated by gel electrophoresis, and
immunoblotted with affinity-purified antibodies prepared against phos-
phopeptides with the sequence surrounding serine 765 or serine 1123 in
synGAP, as described under “Experimental Procedures.” Similar re-
sults were obtained in two experiments.
FIG. 10. Location of phosphorylation sites in synGAP. The dia-
gram indicates the locations of previously identified domains in the
primary sequence of synGAP (10, 11) and the phosphorylation sites
identified in this report. The sites indicated by the large arrows are
identified above them. The small arrow shows the location of serines
1093, 1095, and 1099. The orange bracket indicates the boundaries of
the disordered region predicted by the PONDRs software. The blue
bracket indicates the boundaries of the tandem repeats containing the
phosphorylation sites between residues 750 and 765.
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regions have also been shown to be involved in DNA recogni-
tion, modulation of specificity or affinity of protein binding, and
protein regulation (33). The two principal phosphorylation
sites, 1058 and 1123, are both immediately preceded by a
stretch of polyglycine 13 or 14 amino acids long, broken only by
a few serine residues, which is predicted to be maximally flex-
ible. We detected phosphorylation of sites 1093/95 only in the
S1058A and S1123A double mutant. Thus, their phosphoryla-
tion may be due to the structural flexibility of this region,
permitting phosphorylation of nearby sites in the absence of
the favored sites 1058 and 1123.
We recently found that mutant mice in which synGAP has
been deleted either from conception, or conditionally, a few weeks
after birth, have abnormally high levels of neuronal apoptosis in
several brain regions.2 In addition, preliminary evidence sug-
gests that neurons cultured from mutant mice have alterations in
the timing of activation of Ras following activation of NMDA
receptors.3 Knowledge of the phosphorylated sites that produce
increased GAP activity of synGAP, and the availability of anti-
bodies that specifically recognize those phosphorylated sites, will
provide tools to unravel the precise roles of synGAP in regulation
of synaptic Ras and neuronal apoptosis.
Acknowledgments—We wish to thank Dr. Hong-Jung Chen for some
of the synGAP DNA constructs, Alan J. Rosenstein for excellent tech-
nical assistance, Dr. A. K. Dunker for help with PONDRs software, and
members of the Kennedy laboratory for many helpful discussions.
REFERENCES
1. Sjostrom, P. J., and Nelson, S. B. (2002) Curr. Opin. Neurobiol. 12, 305–314
2. Sheng, M., and Sala, C. (2001) Annu. Rev. Neurosci. 24, 1–29
3. Kennedy, M. B. (2000) Science 290, 750–754
4. Leonard, A. S., Lim, I. A., Hemsworth, D. E., Horne, M. C., and Hell, J. W.
(1999) Proc. Natl. Acad. Sci. U. S. A. 96, 3239–3244
5. Bayer, K. U., De Koninck, P., Leonard, A. S., Hell, J. W., and Schulman, H.
(2001) Nature 411, 801–805
6. Cho, K.-O., Hunt, C. A., and Kennedy, M. B. (1992) Neuron 9, 929–942
7. Kornau, H.-C., Schenker, L. T., Kennedy, M. B., and Seeburg, P. H. (1995)
Science 269, 1737–1740
8. Kennedy, M. B. (1997) Trends Neurosci. 20, 264–268
9. Chen, H.-J., and Kennedy, M. B. (1997) Abstr. Soc. Neurosci. 23, 1466 (abstr.)
10. Chen, H.-J., Rojas-Soto, M., Oguni, A., and Kennedy, M. B. (1998) Neuron 20,
895–904
11. Kim, J. H., Liao, D., Lau, L.-F., and Huganir, R. L. (1998) Neuron 20, 683–691
12. Zhang, W., Vazquez, L., Apperson, M. L., and Kennedy, M. B. (1999) J. Neu-
rosci. 19, 96–108
13. McCormick, F., Martin, G. A., Clark, R., Bollag, G., and Polakis, P. (1991) Cold
Spring Harbor Symp. Quant. Biol. 56, 237–241
14. Komiyama, N. H., Watabe, A. M., Carlisle, H. J., Porter, K., Charlesworth, P.,
Monti, J., Strathdee, D. J., O’Carroll, C. M., Martin, S. J., Morris, R. G.,
O’Dell, T. J., and Grant, S. G. (2002) J. Neurosci. 22, 9721–9732
15. Kim, J. H., Lee, H. K., Takamiya, K., and Huganir, R. L. (2003) J. Neurosci. 23,
1119–1124
16. Oh, J. S., Chen, H.-J., Rojas-Soto, M., Oguni, A., and Kennedy, M. B. (2002)
Neuron 33, 151
17. Miller, S. G., and Kennedy, M. B. (1985) J. Biol. Chem. 260, 9039–9046
18. Carlin, R. K., Grab, D. J., Cohen, R. S., and Siekevitz, P. (1980) J. Cell Biol. 86,
831–843
19. Peterson, G. L. (1983) Methods Enzymol. 91, 95–119
20. Hellman, U., Wernstedt, C., Gonez, J., and Heldin, C.-H. (1995) Analyt. Bio-
chem. 224, 451–455
21. Molloy, S. S., and Kennedy, M. B. (1991) Proc. Natl. Acad. Sci. U. S. A. 88,
4756–4760
22. Bollag, G., and McCormick, F. (1995) Methods Enzymol. 255, 161–170
23. Smith, D. B., and Corcoran, L. M. (1995) in Current Protocols in Molecular
Biology (Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman,
J. G., Smith, J. A., and K., S., eds) Vol. 2, pp. 1671–1677, Wiley Interscience,
New York
24. Kramer, B., Kramer, W., and Fritz, H. J. (1984) Cell 38, 879–887
25. Rose, K., Goldberg, M., and Choi, D. W. (1993) in In Vitro Biological Methods.
Methods in Toxicology (Tyson, C., and Frazier, J., eds) pp. 46–60, Academic
Press, San Diego
26. Annan, R. S., and Carr, S. A. (1996) Anal. Chem. 68, 3413–3421
27. Sheng, M., and Pak, D. T. (2000) Annu. Rev. Physiol. 62, 755–778
28. Li, X., Obradovic, Z., Brown, C. J., Garner, E. C., and Dunker, A. K. (2000)
Genome Inform. Ser. Workshop Genome Inform. 11, 172–184
29. Romero, P., Obradovic, Z., Li, X., Garner, E. C., Brown, C. J., and Dunker, A. K.
(2001) Proteins 42, 38–48
30. Li, X., Romero, P., Rani, M., Dunker, A. K., and Obradovic, Z. (1999) Genome
Inform. Ser. Workshop Genome Inform. 10, 30–40
31. Iakoucheva, L. M., Brown, C. J., Lawson, J. D., Obradovic, Z., and Dunker,
A. K. (2002) J. Mol. Biol. 323, 573–584
32. Dunker, A. K., Brown, C. J., Lawson, J. D., Iakoucheva, L. M., and Obradovic,
Z. (2002) Biochemistry 41, 6573–6582
33. Dyson, H. J., and Wright, P. E. (2002) Curr. Opin. Struct. Biol. 12, 54–60
2 I. Knuesel and M. B. Kennedy, unpublished data.
3 P. Manzerra and M. B. Kennedy, unpublished data.
Regulation of synGAP by CaMKII17988
